<DOC>
	<DOCNO>NCT00375661</DOCNO>
	<brief_summary>The purpose study determine whether low-dose peg-interferon plus ribavirin therapy effective prevention hepatocellular carcinoma ( HCC ) patient curative resection primary HCC .</brief_summary>
	<brief_title>Low-dose Peg-interferon Plus Ribavirin ( IFN/RBV ) Prevention Hepatocellular Carcinoma ( HCC ) Recurrence Patients Who Had Surgery Remove Primary HCC</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Clinical diagnosis Hepatocellular carcinoma due Chronic Hepatitis C Virus Infection . Must treat curative treatment primary tumor use either surgical resection radiofrequency ablation therapy No recurrence hepatocellular carcinoma 3 month primary treatment Renal dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>hepatocellular carcinoma</keyword>
</DOC>